Answers are grounded in this paper and cite their sources.
NEU3 sialidase, a key enzyme in ganglioside metabolism, is activated under hypoxic conditions in cultured skeletal muscle cells (C2C12). NEU3 up-regulation stimulates the EGF receptor signaling pathway, which in turn activates the hypoxia-inducible factor (HIF-1α), resulting in a final increase of cell survival and proliferation. In the same cells, stable overexpression of sialidase NEU3 significantly enhances cell resistance to hypoxia, whereas stable silencing of the enzyme renders cells more susceptible to apoptosis. These data support the working hypothesis of a physiological role played by NEU3 sialidase in protecting cells from hypoxic stress and may suggest new directions in the development of therapeutic strategies against ischemic diseases, particularly of the cerebro-cardiovascular system. Background: NEU3 sialidase removes sialic acid from gangliosides on adjacent cells. Results: NEU3 is up-regulated upon exposure of skeletal myoblasts to hypoxic stress, and it stimulates the EGFR signaling cascade ultimately activating HIF-1α. Conclusion: NEU3 plays a physiological role in protecting myoblasts from hypoxic stress. Significance: NEU3 role in cell response to hypoxia may suggest new therapeutic approaches to ischemic diseases.
No takes yet. Share an insight, caveat, or question.
Scaringi et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: